Search results
Cerevel Sued Over Stock Sale to Bain Ahead of AbbVie Deal News
Bloomberg Law· 1 day agoBain Capital LP affiliates may have arranged to buy stock on the cheap when they knew Cerevel Therapeutics Holdings Inc. was set to be acquired by AbbVie Inc. for $8.7 billion, a newly filed lawsuit says.